These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25704353)

  • 21. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcineurin inhibitor conversion to rapamycin can improve graft function in living donor kidney transplantation with older donors.
    Chen GD; Liu XC; Shi L; Qiu J; Wang CX; Fei JG; Li J; Huang G; Chen LZ
    Transplant Proc; 2013 May; 45(4):1648-50. PubMed ID: 23726640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in kidney transplantation.
    Castillo-Lugo JA; Vergne-Marini P
    Semin Nephrol; 2005 Jul; 25(4):252-60. PubMed ID: 16202698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure control according to the prevalence of diabetes in renal transplant recipients.
    Zbroch E; Malyszko J; Glowinska I; Maciorkowska D; Kobus G; Mysliwiec M
    Transplant Proc; 2013; 45(1):200-4. PubMed ID: 23375300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure control in kidney transplantation: therapeutic implications.
    Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
    J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does antihypertensive therapy modify chronic allograft failure?
    Raine AE
    Kidney Int Suppl; 1995 Dec; 52():S107-11. PubMed ID: 8587270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of a change in immunosuppressive regimen with hemodynamic and inflammatory markers of cardiovascular disease after kidney transplantation.
    Yong K; Nguyen HD; Hii L; Chan DT; Boudville N; Messineo A; Lim EM; Dogra GK; Lim WH
    Am J Hypertens; 2013 Jul; 26(7):843-9. PubMed ID: 23443728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttransplant hypertension: multipathogenic disease process.
    Barbari A
    Exp Clin Transplant; 2013 Apr; 11(2):99-108. PubMed ID: 23473421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and management of hypertension in transplant patients.
    Weir MR; Burgess ED; Cooper JE; Fenves AZ; Goldsmith D; McKay D; Mehrotra A; Mitsnefes MM; Sica DA; Taler SJ
    J Am Soc Nephrol; 2015 Jun; 26(6):1248-60. PubMed ID: 25653099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension after renal transplantation.
    Dikow R; Zeier M; Ritz E
    Minerva Urol Nefrol; 2003 Mar; 55(1):101-9. PubMed ID: 12773971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of predonation hypertension with glomerular function and number in older living kidney donors.
    Lenihan CR; Busque S; Derby G; Blouch K; Myers BD; Tan JC
    J Am Soc Nephrol; 2015 Jun; 26(6):1261-7. PubMed ID: 25525178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival].
    Hernández-Infante E; García-Martínez C; Beltrán-de-la-Luz S; Reyes-Acevedo R; Romo-Franco L; Delgadillo-Castañeda R; Orozco-Loza I; Chew-Wong A
    Rev Invest Clin; 2010; 62(5):398-405. PubMed ID: 21416727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients.
    Büscher R; Vester U; Wingen AM; Hoyer PF
    Pediatr Nephrol; 2004 Nov; 19(11):1202-11. PubMed ID: 15365804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
    Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK
    Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms and consequences of arterial hypertension after renal transplantation.
    Koomans HA; Ligtenberg G
    Transplantation; 2001 Sep; 72(6 Suppl):S9-12. PubMed ID: 11585243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique Considerations When Managing Hypertension in the Transplant Patient.
    Mitema D; Schinstock C
    Adv Exp Med Biol; 2017; 956():341-353. PubMed ID: 27815930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.